Medical News

RSS

Speaker Pelosi's statement on signing of the Ryan White HIV/AIDS Treatment Extension Act

Speaker Nancy Pelosi issued the following statement today after attending a ceremony at the White House where President Obama signed the Ryan White HIV/AIDS Treatment Extension Act into law.

31 Oct 2009

Lipid may be vital to learning

Saturated fats have a deservedly bad reputation, but Johns Hopkins scientists have discovered that a sticky lipid occurring naturally at high levels in the brain may help us memorize grandma's recipe for cinnamon buns, as well as recall how, decades ago, she served them up steaming from the oven.

31 Oct 2009

USCCB calls Catholics to prevent health care reform from being derailed by abortion lobby

In an extraordinary call to Catholics to prevent health care reform from being derailed by the abortion lobby, the United Sates Conference of Catholic Bishops has sent bulletin inserts to almost 19,000 parishes across the country.

31 Oct 2009

Johns Hopkins researchers find life in blood-starved retinas; shed light on vision loss

Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. While many of the molecules involved in guiding the development of the intricate blood vessel architecture are known, only now are we learning how these molecules work and how they might affect sight.

31 Oct 2009

GE Healthcare to showcase its sophisticated imaging systems for oncology at the ASTRO meeting

According to the American Cancer Society, more than one million people are diagnosed with cancer each year. In the United States, about 1 out of every 2 men and 1 out of every 3 women will have some type of cancer at some point during their lifetime. The sooner a cancer is detected and treatment begins, the better the patient’s chances for survival.

31 Oct 2009

Requests to compound liquid Tamiflu have steadily increased over the past couple of weeks

There has been a lot of information about the importance of taking preventative measures against H1N1, primarily through vaccination. But what if a person has already contracted H1N1? What if that person is a young child?

31 Oct 2009

Quintiles and Eisai partner to develop potential oncology products

Quintiles today announced a strategic alliance with leading global pharmaceutical company Eisai Co., Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline. Under the terms of the agreement, Quintiles’ oncology experts will conduct Phase II proof-of-concept studies for 11 solid tumor indications. A key goal of the alliance is to determine the efficacy of the products in the shortest possible time in order to bring therapies to market faster for the benefit of cancer patients worldwide.

31 Oct 2009

WakeMed Health & Hospitals and SCA team up to explore partnership opportunities

WakeMed Health & Hospitals and Surgical Care Affiliates (SCA) have entered into a Letter of Understanding (LOU) under which the two organizations will explore partnership opportunities.

31 Oct 2009

Think First’s recommendation to centralize patient scheduling and registration for ambulatory clinics implemented

Think First announced today that the Hospital of Saint Raphael (HSR) has successfully implemented Think First’s recommendation to centralize patient scheduling and registration for their ambulatory clinics. The Hospital of Saint Raphael has worked closely with Think First consultants to execute this plan and has seen immediate results.

31 Oct 2009

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

31 Oct 2009

CeloNova BioSciences submits a request for approval of its new Embozene Microsphere

CeloNova BioSciences today announced that the company is submitting to its European Notified Body a request for approval of its new, lime green, 2800 micron size Embozene(TM) Microsphere.

31 Oct 2009

Married men more likely to seek professional healthcare compared to single counterparts

According to a Mintel survey of adult men, those who are married are more likely to have had a physical with a registered physician within the past year compared to their single counterparts (55% versus 35%).

31 Oct 2009

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

Novo Nordisk Inc. announced the re-launch of its changing possibilities in hemophilia(TM) campaign through a rebranded Web site and a new community on Facebook®. People living with hemophilia face many daily challenges, and Novo Nordisk is committed to helping this community realize that there is also a lifetime of possibilities.

From Novo Nordisk 31 Oct 2009

New diagnostic test for detecting colorectal cancer

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer.

31 Oct 2009

Immunotherapy, a new therapeutic area to destroy tumor cells

Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).

31 Oct 2009

Study: Gene therapy can reduce symptoms of Huntington's disease

Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.

31 Oct 2009

Miami resident pleads guilty on conspiracy to defraud the Medicare program

Miami resident Daisy Martinez pleaded guilty today in U.S. District Court in Detroit to participating in a conspiracy to defraud the Medicare program, Assistant Attorney General Lanny A. Breuer of the Criminal Division; U.S. Attorney Terrence Berg of the Eastern District of Michigan; Andrew G. Arena, Special Agent-in-Charge of the Detroit Field Office of the FBI; and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS) announced.

31 Oct 2009

Accuray to focus on its CyberKnife Robotic Radiosurgery System at the ASTRO meeting

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that 28 CyberKnife-focused abstracts have been accepted as part of the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), taking place November 1 - 5 in Chicago, Illinois. This represents a 27 percent increase in CyberKnife abstracts over last year's Annual Meeting.

31 Oct 2009

Initiate Systems announces Accenx Technologies acquisition; expands growth strategy in the healthcare market

Initiate Systems, Inc., a leader in data management solutions for information sharing and improved data quality, has acquired Accenx Technologies, Inc., a leading provider of health information exchange solutions. This acquisition furthers Initiate’s growth strategy and expands its offerings in the healthcare market. The terms of the deal are confidential.

31 Oct 2009

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest.

31 Oct 2009

Medical News

Speaker Pelosi's statement on signing of the Ryan White HIV/AIDS Treatment Extension Act

Lipid may be vital to learning

USCCB calls Catholics to prevent health care reform from being derailed by abortion lobby

Johns Hopkins researchers find life in blood-starved retinas; shed light on vision loss

GE Healthcare to showcase its sophisticated imaging systems for oncology at the ASTRO meeting

Requests to compound liquid Tamiflu have steadily increased over the past couple of weeks

Quintiles and Eisai partner to develop potential oncology products

WakeMed Health & Hospitals and SCA team up to explore partnership opportunities

Think First’s recommendation to centralize patient scheduling and registration for ambulatory clinics implemented

iCo Therapeutics announces $4,000,000 brokered private placement

CeloNova BioSciences submits a request for approval of its new Embozene Microsphere

Married men more likely to seek professional healthcare compared to single counterparts

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

New diagnostic test for detecting colorectal cancer

Immunotherapy, a new therapeutic area to destroy tumor cells

Study: Gene therapy can reduce symptoms of Huntington's disease

Miami resident pleads guilty on conspiracy to defraud the Medicare program

Accuray to focus on its CyberKnife Robotic Radiosurgery System at the ASTRO meeting

Initiate Systems announces Accenx Technologies acquisition; expands growth strategy in the healthcare market

Innovative optical system to study the complex mechanisms that lead to sudden cardiac arrest developed

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News